Mesenteric lipofuscinosis is curable because mesenteric lipofuscinosis is a non-specific inflammatory disease. Therefore, the early management is mainly symptomatic, that is, anti-inflammatory and anti-infective treatment. Because this type of disease tends to have relatively limited inflammation in the abdominal cavity, patients do not show obvious signs of peritonitis. It is usually due to a decrease in resistance and other bacteria in the body running into the abdominal cavity, causing infection of the intestinal mesentery and lipid membrane, resulting in pain and inflammation. If the non-specific inflammation causes severe pain, or other complications, it is important to go to the hospital in a timely manner, and if necessary, surgical treatment is required, and depending on the specific situation, surgical methods are chosen to remove the lesion and relieve the compression of the mesenteric vessels and intestinal cavity by the mass. In general, physical exercise can be used to strengthen the body and improve the immune system to avoid re-infection.